Clinical Treatment in Anosmia
A special issue of Journal of Clinical Medicine (ISSN 2077-0383). This special issue belongs to the section "Otolaryngology".
Deadline for manuscript submissions: 31 December 2024 | Viewed by 44
Special Issue Editors
Interests: rhinology; endoscopic sinus and skull base surgery; rhinoplasty; salivary glands; pediatric airway
Interests: olfactory dysfunction; anosmia; smell
Interests: olfactory; gustatory loss; mechanisms involved in irritation of the upper airways; olfaction in neurodegenerative disorders; interactions between the olfactory, trigeminal, and gustatory systems
Interests: eosinophils; allergic diseases; allergy diagnosis; inflammation; airway obstruction; allergy; aerosol medicine; allergic rhinitis; airway remodeling
Special Issue Information
Dear Colleagues,
Olfactory dysfunction (OD) affects a large proportion of the general population, and its incidence is increasing due to the COVID-19 pandemic. OD has a significant impact on the quality of life of these patients, with negative effects on nutrition, social function and mental health. A large body of literature on the application of effective treatments for OD currently exists; however, the results of these studies remain non-optimal.
We are pleased to invite you to submit a manuscript to this Special Issue entitled “Clinical Treatment in Anosmia”, which aims to describe all the available treatment options for this pathology, including medications, olfactory training and various novel therapies. The insertion of biologics into sinonasal disease management, olfactory training modifications and platelet-rich plasma injections are all examples of recent advances in the field; these are accompanied by studies concerning future therapeutic options such as olfactory implants, stem cell therapies and gene therapy. It is evident that the whole scientific field of OD treatment has garnered significant research interest.
This Special Issue aims to focus on these efforts in order to present recent clinical and experimental research on anosmia treatment worldwide.
In this Special Issue, original research articles and reviews are welcome. The scope of this Special Issue includes the following: studies on local and systemic medications, olfactory training, novel therapies, future options, and patient perspectives.
We are looking forward to receiving your contributions.
Dr. Iordanis E. Konstantinidis
Dr. Moustafa Bensafi
Prof. Dr. Thomas Hummel
Dr. Macchi Alberto
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Journal of Clinical Medicine is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- anosmia
- olfactory dysfunction
- parosmia
- olfactory training
- olfactory implant
